Drug Type Small molecule drug |
Synonyms SNS 510, SNS-510 |
Target |
Mechanism PDK1 inhibitors(3-phosphoinositide-dependent protein kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 29 Oct 2019 | |
Hematologic Neoplasms | Preclinical | US | - | |
Sarcoma | Preclinical | US | - | |
Solid tumor | Preclinical | US | - |